Halozyme Announces Preclinical Data Presentations At The Association Of …MarketWatchThe first presentation includes preclinical data showing that treatment of tumors with PEGPH20 enhances the action of immune-based cancer therapy such as monoclonal a…
Gene, immune therapy help cancer warU-T San DiegoStanford University researcher Irving Weissman explains how the drug Rituxan, generically called rituximab, improves the cancer-killing effect of a new antibody that renders cancer cells vulnerable to im…
Celiac.com |
Persistently High Antibodies Reveal Non-responsive Celiac Disease
Celiac.com Jefferson Adams is a freelance writer living in San Francisco. His poems, essays and photographs have appeared in Antioch Review, Blue Mesa Review, CALIBAN, Hayden’s Ferry Review, Huffington Post, the Mississippi Review, and Slate among others. |
album reviews site:#*/] Buy cheap albendazolealbum reviews siteWhat to consider using rituximab, think about what words youre going to use, repetitive the in buy cheap albendazole enough procedure go! Arent you starting the argument. To avoid the traf…
|
Pharmaceutical companies to benefit from new blood cancer drugs
The Pharma Letter … (ibrutinib) will be among the biggest products in blood cancer treatments, and has recently been approved for CLL, while Roche/Biogen Idec’s Gazyva (obinutuzumab) could eventually more than replace its lucrative but mature Rituxan(rituximab … |
Method for delivering HIV-fighting antibodies proves even more promisingdomain-BIn 2011, biologists at the California Institute of Technology (Caltech) demonstrated a highly effective method for delivering HIV-fighting antibodies to mice-a treatment th…
Mushrooms shown to help in fighting cancermySteinbach.ca (blog)There is also an early phase study being conducted on young patients to determine whether beta glucan can increase the effectiveness of rituximab, a drug used in treating some types of lymp…
|
Patents, biosimilars and trademarks – another triangle?
Lexology (registration) Although Roche was taking steps to use Emcure Pharmaceuticals in India “to produce its innovative biologics in India” and to reduce the price for cancer drugs trastuzumab (Herceptin) and rituximab (MabThera), in a surprising but strategic move, Roche … |
Experts Praise Drug Trial for Creating a Realistic Study PopulationMonthly Prescribing ReferenceResearchers compared the benefits of obinutuzumab with that of another antibody rituximab, which also attacks CD20. Both drugs were combined with the chemot…
|
Monoclonal Antibodies Market in Colorectal Cancer to 2019 – Favorable Pricing …
SYS-CON Media (press release) GBI Research, has released the pharma report “Monoclonal Antibodies Market in Colorectal Cancer to 2019 – Favorable Pricing Policy in the US and Rising Prevalence in Europe and Japan Ensures Market Growth”. There are currently three monoclonal … |